Acknowledgments
SCIENTIFIC COMMITTEE
- Lambert Busque, Chief Medical Officer, C3i
- David Courtman, Biotherapeutics Manufacturing Centre, The Ottawa Hospital Research Institute
- Danielle Deverteuil, Business development & operations manager, Biomarker unit, C3i
- Julie Fradette, Researcher, Centre de Recherche en Organogénèse Expérimentale de l’Université Laval/ LOEX, Director, ThéCell CHU de Québec Research Center-Université Laval
- Craig Hasilo, Chief Scientific Officer, CellCAN
- Armand Keating, Director, Cell Therapy Program, University Health Network
- Bernard Massie, Director General (acting), Human Health Therapeutics Research Centre, National Research Council of Canada
- Michael May, CEO, CCRM
- Véronique Moulin, Researcher, Centre de Recherche en Organogénèse Expérimentale de l’Université Laval/ LOEX, CHU de Québec Research Center-Université Laval
- Denis Claude Roy, Chief Executive Officer, CellCAN
- Duncan Stewart, Executive Vice-President of Research, The Ottawa Hospital, CEO and Scientific Director, The Ottawa Hospital Research Institute
ORGANIZING COMMITTEE
- Véronique Arsenault, Consultant in Communications and Media Relations, Exponentiel Conseil
- Marie-Ève Desormeaux, Project Manager, CellCAN
- Vanessa Laflamme, Chief Operating Officer, CellCAN
- Mathieu Lavallée, Consultant in Public Relations, Exponentiel Conseil
EVENT COORDINATION TEAM
Créatures
Branding and artistic production www.creatures.ca
Freeman Audiovisual
Technical and logistical direction freemanav-ca.com
Onyris
Web solutions
www.onyris.com
The Omni King Edward
Facilities, hospitality and banquet services www.omnihotels.com
THANK YOU FOR MAKING THIS EVENT A SUCCESS!